Travere Therapeutics (TVTX) PT Raised to $80 at Wells Fargo

August 6, 2026 6:38 AM

Wells Fargo analyst Mohit Bansal raised the price target on Travere Therapeutics (NASDAQ: TVTX) to $80.00 (from $65.00) while maintaining a Overweight rating.

No results found